# OCREVUS

NDC: 50242-150
Generic name: ocrelizumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20170328

FDA application: BLA761053

## Active ingredients

- OCRELIZUMAB: 300 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-150"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-150
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9da42362-3bb5-4b83-b4bb-b59fd4e55f0d